Tempest Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
986
across all filing types
Latest filing
2026-06-04
Board/Management Inform…
Country
US
United States of America
Listing
US
TPST
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47971689 | 8-K | 2026-06-04 | English | ||
| 47932149 | 8-K | 2026-06-01 | English | ||
| 47894406 | 8-K | 2026-05-29 | English | ||
| 46862577 | 8-K | 2026-05-22 | English | ||
| 46861258 | 8-K | 2026-05-22 | English | ||
| 46273317 | 10-Q | 2026-05-14 | English | ||
| 46272554 | 8-K | 2026-05-14 | English | ||
| 41819645 | 8-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-05-06 | English | ||
| 33995585 | 424B3 - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-04-10 | English | ||
| 33995582 | 424B3 - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-04-10 | English | ||
| 33111031 | S-8 POS - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-31 | English | ||
| 33088252 | 10-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-30 | English | ||
| 33088089 | 8-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-30 | English | ||
| 33043165 | SCHEDULE 13D/A - Tempest Therapeutics, Inc. (0001544227) (Subject) | 2026-03-25 | English | ||
| 33043162 | 4 - Tempest Therapeutics, Inc. (0001544227) (Issuer) | 2026-03-25 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
PYC THERAPEUTICS LIMITED
Clinical-stage developer of RNA-based precision medicines f…
|
PYC | AU | Professional, scientific and te… |
|
Q32 Bio Inc.
A clinical-stage biotech developing therapies for autoimmun…
|
QTTB | US | Professional, scientific and te… |
|
QinetiQ Group PLC
A science and engineering company providing technology for …
|
GB | Professional, scientific and te… | |
|
Qualigen Therapeutics, Inc.
Clinical-stage biotech developing novel cancer treatments f…
|
QLGN | US | Professional, scientific and te… |
|
Quanterix Corp
Digitizes biomarker analysis with an ultra-sensitive digita…
|
QTRX | US | Professional, scientific and te… |
|
Quantum Base Holdings PLC
Develops quantum-secure fingerprints for product authentica…
|
QUBE | GB | Professional, scientific and te… |
|
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC
An R&D company using AI and quantum computing to enhance Bi…
|
QBT | GB | Professional, scientific and te… |
|
Quantumzyme Corp.
A biotransformation company specializing in enzyme engineer…
|
QTZM | US | Professional, scientific and te… |
|
QUIA PHARMA AB
Develops medicines using a proprietary drug delivery platfo…
|
QUIA | SE | Professional, scientific and te… |
|
Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGv…
|
115180 | KR | Professional, scientific and te… |
Tempest Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34632/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34632 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34632 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34632 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34632}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tempest Therapeutics, Inc. (id: 34632)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.